公开(公告)号：US20240189257A1

公开(公告)日：2024-06-13

申请号：US18282672

申请日：2021-03-25

Applicant: SAMI-SABINSA GROUP LIMITED

Inventor： Muhammed Majeed ,  Kalyanam Nagabhushanam ,  Sarang Bani ,  Anjali Pandey

IPC: A61K31/12 ,  A61K31/37 ,  A61K31/7034 ,  A61K36/185 ,  A61K36/48 ,  A61P13/12

CPC classification number: A61K31/12 ,  A61K31/37 ,  A61K31/7034 ,  A61K36/185 ,  A61K36/48 ,  A61P13/12

Abstract: The invention discloses the use of a composition comprising 70%-80% w/w tetrahydrocurcuminoids, 10%-20% w/w hexahydrocurcuminoids and 5%-10% w/w octahydrocurcuminoids in the therapeutic management of nephropathy in mammals. The composition further comprises β-glucogallin and total mucic acid gallates, C-glucosides and tannins isolated from Pterocarpus marsupium. The invention also discloses the potential of the composition comprising β-glucogallin and total mucic acid gallates from Emblica officinalis, C-glucosides and tannins isolated from Pterocarpus marsupium in the therapeutic management of nephropathy.